Insight · DES
Insight — PCN DES 2026/27 explained.
The shape of the contract — a recap.
The Network Contract DES sets out the services PCNs must deliver, the financial flows that support them, and the workforce framework — including the Additional Roles Reimbursement Scheme — that underpins delivery. For most Clinical Directors the contract operates through four pressure points: enhanced access, structured medication reviews, the impact and investment fund, and ARRS workforce deployment. Pharmacist and technician roles sit at the centre of three of those four.
Headline changes for 2026/27
What's actually different this year.
- Sharper supervision evidence requirements for ARRS-funded clinical roles
- Tighter outcomes reporting expectations tied to IIF and QOF indicators
- Continued emphasis on structured medication reviews for over-65 polypharmacy cohorts
- Active ICB stance on recycling unused ARRS allocation within the year
- Continued integration of pharmacy technician roles within ARRS
Where pharmacist roles fit
How pharmacist capacity maps to DES requirements.
Pharmacist and technician capacity inside a PCN is not a single role doing one thing. It is a programme that maps to several DES requirements simultaneously — and the PCNs that get the most out of their ARRS allocation treat it that way. A well-deployed pharmacist programme covers structured medication reviews, hospital discharge reconciliation, high-risk drug monitoring, QOF indicator improvement, GP workload reduction and care home medicines safety, with technicians absorbing repeat prescribing and prescribing audit work alongside.
- Structured Medication Reviews — pharmacist-led, technician-supported
- Discharge reconciliation — pharmacist or technician depending on volume
- QOF cardiovascular, diabetes, respiratory and CKD support
- IIF medicines safety indicators
- Annex B supervision evidence built in
The supervision question — taken seriously.
The single area where the 2026/27 contract bites hardest is supervision. ARRS-funded pharmacist roles have always required clinical supervision; the difference is that ICBs are increasingly asking PCNs to evidence it during the year, not just at audit. That means a documented supervision schedule, a CPD log, an escalation route and a named senior pharmacist signing the supervision off. PCNs running solo recruitment frequently struggle here; PCNs working with a managed provider almost never do, because the supervision is built into the service rather than bolted on.
What good DES delivery looks like
The PCN checklist for 2026/27.
- Documented role map showing how each ARRS role contributes to DES requirements
- Supervision schedule signed off by a senior clinical pharmacist
- Monthly outcomes report tied to QOF and IIF indicators
- Structured medication review programme with a defined cohort
- Discharge reconciliation SLA with the local trust
- Care home medicines safety programme where care home patients sit within the PCN
- Year-end ARRS deployment plan that lands above 95 per cent of allocation
What changes practically for Clinical Directors.
For a Clinical Director, the contract changes translate into three practical asks. One: get supervision documented now, not in March. Two: make sure outcomes reporting is happening monthly and is tied to indicators the ICB will recognise. Three: have a credible plan for any ARRS underspend by Q3 — late mobilisation is harder every year as ICBs sharpen their expectations. Clinical Directors who get those three in place generally find the rest of the contract delivers itself.
FAQs — the 2026/27 DES.
Is the DES contract optional?+
In practice no — almost every PCN signs up. The DES is the primary contract through which PCN funding flows.
What happens if we miss IIF indicators?+
IIF achievement affects PCN income directly. Pharmacist input is one of the most cost-effective ways to move several IIF indicators.
Do we need a managed provider to comply?+
No. Many PCNs comply through direct recruitment. A managed provider removes the supervision, cover and governance overhead — particularly useful for smaller or under-resourced PCNs.
Where does BCS fit?+
BCS provides the pharmacist and technician workforce, the supervision, the governance and the outcomes reporting that the DES expects.
Talk to BCS.
If you'd like to walk through what this would look like for your PCN specifically, talk to our Service Development team. We'll cost a plan against your remaining ARRS allocation and your existing pharmacy workforce, and have a written proposal back within a week.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.